Recent Articles from Business Wire

The Cheesecake Factory® (NASDAQ: CAKE), known for its extensive menu, generous portions and legendary desserts, is putting the restaurant experience right at its guests’ fingertips, introducing a new app with a sweet offer for Cheesecake Rewards members. On April Fools’ Day through April 30, Rewards members who download the app and log in to their account will receive a free slice of any of The Cheesecake Factory’s more than 30 legendary flavors of cheesecake or layer cake with any purchase* – no joke!

Viamericas, a leading provider of remittance and international money transfer services, today announced the opening of a new operations and service hub in Tijuana, Mexico, as part of its long-term growth strategy. The new hub reflects the company’s continued investment in its people and in the operational capabilities required to support evolving customer needs and expanding business opportunities.

auxi AI, the leading AI-powered PowerPoint productivity software, today announced the launch of Darwin, a purpose-built AI agent designed specifically for enterprise consulting firms and investment banks. Darwin enables teams to build high-impact decks faster, with greater accuracy, brand compliance, and strategic depth.

VideaHealth, the leading dental AI platform, today announces that Emergency Dental of America has deployed Videa across its network of 22 practices following a successful pilot. The rollout brings ambient clinical documentation to one of dentistry's most demanding care settings, where providers often have limited time between patients to complete notes.

Dear Fellow Shareholders,

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced the nomination of a development candidate under its collaboration and exclusive worldwide license agreement with Bristol Myers Squibb. The milestone was achieved following the identification of a tumor-activated therapeutic, utilizing Janux’s TRACTr platform, targeting an undisclosed solid tumor antigen expressed across several human cancer types, triggering a $35 million milestone payment to Janux.

Jackson Healthcare®, the trusted authority in healthcare talent and workforce solutions, today announced it has been named to the newly published 2026 Fortune® 100 Best Companies to Work For® list recognizing organizations with exceptional workplace culture and high employee satisfaction. This marks the company’s third consecutive appearance in the prestigious lineup.

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit sales for its CyPath® Lung diagnostic in the first quarter of 2026 exceeded internal projections and, based on preliminary unaudited data, achieved 146% growth compared to the first quarter of 2025, reflecting accelerating physician adoption and expanding clinical use of the Company’s noninvasive lung cancer diagnostic test.

Netceed, a global leader in delivering supply chain solutions across broadband, data center and energy infrastructure, today announced the appointment of Franck Bruel, Jan Frykhammar and Stacey Thompson to advise as strategic advisors to its Board of Directors.

Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular applications, today announced enrollment of the first patients in FLAGSHIP, the Company’s prospective, single‑arm, open‑label first‑in‑human study evaluating its investigational False Lumen Embolization (FLE) System for the treatment of aortic dissection.

RLJ Lodging Trust (the “Company”) (NYSE: RLJ) today announced it will report financial results for the first quarter ended March 31, 2026, before the markets open on May 4, 2026. The Company will also host a conference call on May 4, 2026, at 11:00 a.m. (Eastern Time).

Allianz Investment Management LLC (AllianzIM), a subsidiary of Allianz Life Insurance Company of North America (Allianz Life) and adviser to the AllianzIM exchange-traded funds (ETFs), today announced the expansion of its Buffered ETF lineup with the launch of eight new strategies that seek to give investors more ways to stay invested while managing downside risk. The launch expands the international Uncapped Buffered series and introduces seven quarterly-reset, single-ticker buffered ETFs that offer investors exposure to the S&P 500 Index, Russell 2000 Index, Nasdaq-100 Index and developed international equities (investors are not directly invested in the index). Each fund provides a clearly defined downside buffer and an upside participation level tied to its respective index, offering straightforward implementation for advisors and investors.

Newegg Commerce, Inc. (NASDAQ: NEGG) – Newegg brought collegiate esports competition to its Southern California headquarters, hosting a live VALORANT tournament in collaboration with Evil Geniuses, North America’s premier esports and gaming organization.

Landmark Bio, an Artis BioSolutions company dedicated to accelerating the translation of next-generation advanced therapies from discovery to clinical and commercial production, today announced that it has secured an Advanced Research Projects Agency for Health (ARPA-H) award totaling up to $18.3 million to build an efficient, robust, and scalable continuous manufacturing platform for extracellular vesicles (EVs). The TRANSFORM EV project aims to address unmet needs in drug delivery by overcoming barriers to commercialization and broadening patient access to transformative EV-based therapeutics. This will be accomplished by establishing advanced domestic manufacturing capabilities that overcome the limitations of current low-yield, high-cost processes.

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the pivotal results from the FULCRUM-VT study have been accepted for presentation in a late-breaking clinical science session at Heart Rhythm 2026 (HRS), the annual meeting of the Heart Rhythm Society. This is the first Investigational Device Exemption (IDE) study powered to evaluate the safety and effectiveness of Ultra-Low Temperature Ablation (“ULTA”, formerly “ULTC”) for the treatment of scar-related ventricular tachycardia (VT) in both ischemic and non-ischemic population.

Ray Therapeutics (RayTx), a clinical-stage biopharmaceutical company pioneering optogenetic therapies for those living with retinal degenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to its lead candidate, RTx-015, for the treatment of retinitis pigmentosa (RP).

Summer Road LLC (“Summer Road”), the beneficial owner of approximately 3% of the outstanding shares of Class A common stock of Ingles Markets, Incorporated (NASDAQ: IMKTA) (“Ingles” or the “Company”), today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with Ingles’ 2026 Annual Meeting of Shareholders to be held on April 30, 2026.

Aptus Capital Advisors, LLC (Aptus) today announced the launch of a laddered buffer ETF, with the 0.30% total expense ratio designed to deliver better value than presently-available choices. ABUF offers the attributes of risk mitigation and tax efficiency that have driven the use of buffered funds, but adds a level of consistency for advisors incorporating these funds in strategic asset allocations.

Teledyne Technologies Incorporated (NYSE:TDY) is excited to announce the integration of the company’s extensive portfolio of space-focused technologies and businesses, reinforcing its long-term commitment to the global space sector.

The DJS Law Group reminds investors of a class action lawsuit against Pinterest, Inc. (“Pinterest” or “the Company”) (NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Nocion Therapeutics, Inc., a biopharmaceutical company developing novel small molecule therapies that selectively silence activated sensory neurons, today announced the expansion of its Board of Directors with the appointment of Mark Iwicki, a recognized leader in building and maximizing value in biopharmaceutical companies, including through successful strategic transactions.

Wellpoint, a health benefits company in Massachusetts, is once again partnering with the Boston Bruins to kick off the Second Annual Teachers' Lounge Makeover Contest, recognizing teachers and school personnel for their contributions to our communities. The community is invited to nominate outstanding schools, where their respective teachers and staff have gone above and beyond to enrich student lives and enhance educational outcomes.

Amphenol Corporation (NYSE: APH) (the “Company” or “Amphenol”), as part of its completed acquisition (the “CCS Acquisition”) of the Connectivity and Cable Solutions business from Vistance Networks, Inc. (formerly known as CommScope Holding Company, Inc., or “Seller”), had previously announced its open offer to acquire up to 1,196,000 fully paid-up equity shares of face value of INR 10 of ADC India Communications Limited (the “Target Company”), representing 26.00% of the Target Company’s voting share capital, from the public shareholders of the Target Company, pursuant to and in compliance with the requirements of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended (the “SEBI (SAST) Regulations”) (the “Open Offer”). After the completion of the CCS Acquisition, the Target Company became an indirect majority-owned subsidiary of Amphenol.

SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq: STKL) (TSX: SOY), a North American supply chain solutions provider, today announced that leading independent proxy advisory firms Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) have both recommended that SunOpta’s shareholders vote “FOR” the proposed acquisition of the Company by an affiliate of Refresco Holding B.V. ("Refresco") at the Company’s upcoming special meeting of shareholders (the “Shareholder Meeting”) scheduled for April 16, 2026 at 10:00 a.m. (Eastern Time) via live audio webcast online at www.virtualshareholdermeeting.com/STKL2026SM.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2026 before the market opens on Thursday, April 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations.

ChargePoint (NYSE: CHPT), a global leader in electric vehicle (EV) charging solutions, today announced that the company has enabled over 90 charging ports for the South Coast Air Quality Management District (South Coast AQMD), the regulatory agency responsible for improving air quality in Los Angeles, Orange, Riverside, and San Bernardino counties. The deployments provide employees and the public with convenient and reliable EV charging solutions.

Viking® (www.viking.com) (NYSE: VIK) today announced its two newest ships for the Nile River—the Viking Ptah and the Viking Sekhmet—have been “floated out,” marking a major construction milestone and the first time the ships have touched water. Set to debut in September and November 2026, respectively, the Viking Ptah and the Viking Sekhmet will join the company’s growing fleet of state-of-the-art ships in Egypt and will sail Viking’s popular 12-day Pharaohs & Pyramids itinerary.

FUJIFILM Americas today announces the refresh of the official sponsor website for one of the world’s most exciting emerging professional golfers -Rio Takeda - in advance of the FUJIFILM Studio Alice Ladies Open, a key Japan Ladies Professional Golfers' Association (JLPGA) tournament that is scheduled to take place April 10-12 in Ishizaka GC, Saitama. As a proud sponsor of Rio since July 2024, Fujifilm supports her aspiration to become a world-class golfer and resonates with her commitment to facing challenges with sincerity and her philosophy of embracing every obstacle with a smile.

Halliburton (NYSE: HAL) and Sumitomo Corporation (TYO: 8053) today announced that Halliburton acquired Sekal AS (“Sekal”). Sekal is a global leader in digital drilling autonomy and, prior to Halliburton’s acquisition, was a fully owned subsidiary of Sumitomo Corporation.

GALT Aerospace (“GALT,” or the “Company”), a leading defense innovator delivering warfighter centric command, control, and communications (“C3”) solutions for airborne systems, today announced that it has received a strategic investment from Godspeed Capital Management LP (“Godspeed”), a lower middle-market Defense & Government services, solutions, and technology-focused private equity firm. The financial terms of the transaction were not disclosed.

Talica is pleased to announce the acquisition of AeroDynamics Metal Finishing, a Seabrook, New Hampshire – based provider of precision surface treatments supporting aerospace, defense, medical device, and other high-performance and technically demanding industrial applications.

Long Tail (the “Company”), a leading provider of AI-native software and services for utilization management, physician advisory and denials and appeals workflows across hospitals, medical centers and health systems, today announced it has received a strategic investment from Eir Partners Capital (“Eir Partners” or the “Firm”). Terms of the transaction were not disclosed.

Shake Shack Inc. (“Shake Shack” or the “Company”) (NYSE: SHAK) today announced Project Catalyst, a comprehensive technology initiative to scale its digital, data, and operational platforms as the Company expands to 1,500 Company-operated Shacks.

The latest quarterly U.S. Bank Freight Payment Index – Rates Edition showed truck freight rates moving up modestly to start 2026, while the gap between spot and contract pricing has narrowed.

SoFi Technologies, Inc. (NASDAQ: SOFI), the one-stop shop for digital financial services, today announced plans to host a conference call to discuss financial and operating results for the first quarter of 2026 on Wednesday, April 29, 2026, at 8 a.m. Eastern Time. SoFi also plans to release its first quarter 2026 results on the investor relations section of its website at https://investors.sofi.com at approximately 7 a.m. Eastern Time on Wednesday, April 29, 2026.

Senzing, developers of industry-leading entity resolution technology, today announced that Stephen Gilderdale has joined the company as President & Chief Commercial Officer. In this role, Gilderdale will lead the company’s global commercial organization, with responsibility for sales, partnerships, marketing, and revenue operations.

YCharts, a leading investment research and client engagement platform trusted by financial professionals across North America, today announced an enterprise-wide partnership with Axtella, an organization supporting a network of independent financial professionals across its affiliated broker-dealer and RIA firms. The expanded agreement builds on a relationship established in 2023 and now extends YCharts access to more than 800 of Axtella's financial professionals.

Voro Therapeutics, a biotechnology company pioneering tumor-activated biologics to improve the safety and efficacy of cancer therapies, today announced upcoming oral presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 and the Antibody Engineering & Therapeutics (AET) Europe conference.

Align Capital Partners (“ACP”) announced today the successful closing of a single asset continuation fund (“CP EV Fund I, LP”) with approximately $405 million in commitments to support the next phase of growth for its tech-enabled legal services platform Proceed (the “Company” or “Proceed”). ACP acquired Counsel Press in October 2023 and rebranded the Company as Proceed last year after completing twelve add-on acquisitions.

QAD | Redzone, the company redefining manufacturing and supply chains through intelligent, adaptive solutions, announced the appointments of Sania Khan as GM ERP - EMEA & APAC, and Rowan Scranage as GM ERP - Americas.

Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform.

Resultant, a leading data and technology consulting firm, today announced that it has acquired Liberty Advisor Group, a Chicago-based consulting firm specializing in M&A advisory services for private equity firms and Fortune 500 companies. The acquisition creates a comprehensive M&A lifecycle platform, merging Liberty’s transaction advisory expertise with Resultant’s data and digital transformation execution capabilities.

Hamilton Reserve Bank, the largest global bank headquartered in the Caribbean with more than US$ 6 billion in assets, is sponsoring student athletes and coaches from St. Lucia to compete in Penn Relays USA in Philadelphia, marking St. Lucia’s first-ever appearance, April 23 to April 25, 2026. Affiliated with the world-renowned University of Pennsylvania, Penn Relays is the oldest and largest track and field competition in the U.S. Hamilton Reserve Bank is an official sponsor of Penn Relays.

Vontier Corporation (NYSE: VNT), a leading global provider of critical technologies and solutions to connect, manage and scale the mobility ecosystem, received a gold rating by EcoVadis, placing the company in the top 5% of more than 150,000 businesses assessed for sustainability performance.

Schmidt Industrial Services LLC (“Schmidt Industrial”), a leading provider of engineered metal solutions, pressure vessels and precision machining services, today announced the acquisition of Metal & Cable Corp, a recognized leader in magnetic mounting equipment and specialty metal sourcing. This strategic acquisition strengthens Schmidt Industrial’s position across telecommunications, energy, and power markets while further diversifying its capabilities in metal fabrication and precision machining.

Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline of its Biologics License Application (BLA) for Orca-T for the treatment of patients with hematologic malignancies. The new Prescription Drug User Fee Act (PDUFA) target action date is July 6, 2026.

Foley Hoag announced the launch of a First Amendment and Media practice group in conjunction with its addition of nationally recognized First Amendment litigators Michael Grygiel and Kelly McNamee, who join as partners. Grygiel and McNamee have built one of the most respected media law practices in the country. Grygiel will chair the practice group, and he, McNamee, and associate Christina Hernsdorf will all be based in New York.

Montieth & Company (M&Co), a global specialist communications consultancy, is proud to announce the appointment of Jeff Segvich as Global Director, leading the firm’s UK and EMEA business. Jeff’s experience and expertise strengthen the firm’s Global Leadership Team as it launches a new series of growth initiatives to accelerate and expand our integrated, flexible, and efficient cross-border offering across the UK/EMEA, North America, and several Asia-Pacific money and media markets.

Penguin Solutions, Inc. (“Penguin Solutions” or the “Company”) (Nasdaq: PENG) today announced that SMART Modular Technologies (LX) S.à r.l. (“Seller”), a wholly owned indirect subsidiary of the Company, closed the transaction contemplated by that certain Stock Transfer Agreement (the “Stock Transfer Agreement”) entered into on December 29, 2025, by and among Seller, Lexar Europe B.V. (“Buyer”), Zilia Technologies Indústria e Comércio de Componentes Eletrônicos Ltda. (“Zilia Technologies”) (formerly SMART Modular Technologies do Brasil - Indústria e Comércio de Componentes Ltda.), Shenzhen Longsys Electronics Co., Ltd., and Shanghai Intelligent Memory Semiconductor Co., Ltd. (上海慧忆半导体有限公司).

Great Place To Work® and Fortune media have recognized World Wide Technology (WWT) as one of the Fortune 100 Best Companies to Work For® in 2026.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older.

New Era Energy & Digital, Inc. (Nasdaq: NUAI) (“New Era” or the “Company”), a developer and operator of next-generation digital infrastructure and integrated power assets in the Permian Basin, today announced that it has entered into a non-binding letter of intent (“LOI”) to form a joint venture for the development and financing of its Texas Critical Data Centers campus (“TCDC”) in West Texas.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced a global clinical trial collaboration with Amgen Inc. (NASDAQ: AMGN) to evaluate Zai Lab’s investigational delta-like ligand 3 (DLL3)-targeting antibody-drug conjugate (ADC), zocilurtatug pelitecan (zoci, formerly ZL-1310), in combination with Amgen’s IMDELLTRA® (tarlatamab-dlle), a DLL3-targeting Bispecific T-cell Engager (BiTE®) therapy in patients with extensive-stage small cell lung cancer (ES-SCLC).

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy.

InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include Semiconductor, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, and Safety/Security, today announced that Rich Rogoff, Division President of InTest’s Environmental Technologies Division, has also been named President and Chief Executive Officer of InTest Corporation and appointed to the InTest Board of Directors, replacing Nick Grant who has served as President, CEO and Board member since 2020, effective immediately.

Children’s Hospital Los Angeles (CHLA) is marking its 125th anniversary, celebrating more than a century of advances in pediatric medicine through clinical excellence, surgical innovation, and scientific discovery. CHLA consistently ranks among the nation’s top 10 children’s hospitals on U.S. News & World Report’s Honor Roll of Best Children’s Hospitals, earning international recognition as a destination for families seeking specialized pediatric care.

Vince Holding Corp., (Nasdaq: VNCE) (“VNCE” or the “Company”), a global retail platform, today announced that it plans to report its fourth quarter and fiscal year 2025 financial results pre-market on Wednesday, April 15, 2026. The Company also plans to hold a conference call to discuss its financial results on the same day at 8:30 a.m. ET. During the conference call, the Company may answer questions concerning business and financial developments, trends and other business or financial matters. The Company's responses to these questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been previously disclosed.

The DJS Law Group reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. (“Aldeyra” or “the Company”) (NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth.

New Fortress Energy Inc. (NASDAQ: NFE) (“NFE” or the “Company”) previously announced on March 17, 2026 that it entered into a Restructuring Support Agreement (“RSA”) with its creditors as part of a consensual UK Restructuring Plan (“UK RP”).

Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, will release its first quarter 2026 financial results after the close of trading on the NYSE on Wednesday, May 6, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife's senior management team will host an audio webcast and conference call to discuss its recent financial results.

Cyclerion Therapeutics, Inc. (“Cyclerion”) (Nasdaq: CYCN) and Korsana Biosciences, Inc. (“Korsana”), a privately-held biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that they have entered into a definitive merger agreement for an all-stock transaction. Upon completion of the transaction, the combined company plans to operate under the name Korsana Biosciences, Inc. and trade on Nasdaq under the ticker symbol “KRSA.”

Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a series of strategic milestones that underscore the company’s accelerating growth, expanding international footprint, and continued commitment to advancing earlier and more accurate diagnosis of neurodegenerative diseases.

Blue Vault, a leading aggregator of alternative investment performance data and analysis, today announced the launch of its new research portal, delivering a streamlined, data-rich way for investment advisors, financial services enterprises, and asset managers to evaluate and compare investment opportunities in private credit, real estate, and equity. Blue Vault researches publicly registered nontraded REITs, nontraded BDCs, interval funds, and tender offer funds, and coming in April, DST offerings.

Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that PCL Construction has selected Navan to spearhead its global travel and expense transformation.

Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems.

Bruker Corporation (Nasdaq: BRKR) announces the appointment of Mr. Thierry L. Bernard to serve on its Board of Directors, effective as of today. Mr. Bernard is an international life-science tools and diagnostics industry executive with decades of relevant leadership, strategic and operational experience.

Acrisure, a global fintech leader, today announces it has completed the acquisition of Vave, a technology-driven property MGA, from Canopius Group.

Brightstar Capital Partners (“Brightstar”), a middle-market private equity firm focused on control-oriented investments in business services, industrials, technology, media & telecom, and financial services companies, today announced that Eric Epstein will join the firm as Partner and Co-Chair, effective May 1, 2026. Mr. Epstein brings more than three decades of experience in capital formation, investor relations, and investment firm leadership, including serving as Partner and President of Davidson Kempner Capital Management during a period of substantial growth and global expansion.

As the first wave of Gen X approaches retirement, many consumers are confronting a difficult transition: after decades focused on growing assets, they now must convert those savings into reliable income, often without the pension safety nets previous generations often relied on.

As the United States faces a projected shortfall of more than five million skilled workers by 2032, correctional systems are emerging as an untapped engine for workforce development. Yet persistent digital access gaps and limited pathways to education and employment continue to restrict economic mobility for incarcerated individuals from Day One.

OPAL Fuels (Nasdaq: OPAL) completed the sale of $23 million in Inflation Reduction Act (IRA) investment tax credits (ITCs) generated by the Atlantic Renewable Natural Gas (RNG) Facility, located in Egg Harbor Township in New Jersey. OPAL Fuels’ share of the ITCs sold was $11.5 million.

FirstSun Capital Bancorp (“FirstSun”) (NASDAQ: FSUN), the holding company for Dallas-based Sunflower Bank, N.A. (“Sunflower Bank”), today announced that it has completed its merger with First Foundation Inc. (“First Foundation”), a bank holding company with two wholly owned operating subsidiaries, First Foundation Advisors and First Foundation Bank, in an all-stock transaction. Also on April 1, 2026, First Foundation Bank merged with and into Sunflower Bank, with Sunflower Bank continuing as the surviving bank.

Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that its advanced optical imaging and sun sensor technology will launch on board the Orion spacecraft as part of NASA’s Artemis II mission, the first crewed mission for the Artemis program. Through contracts with Lockheed Martin, NASA’s prime contractor for Orion, Redwire is responsible for the production and testing of the Orion Camera System for Artemis missions I-V.

Alkermes plc (Nasdaq: ALKS) today announced the initiation of the Brilliance Studies, a phase 3 program evaluating the safety and efficacy of alixorexton compared to placebo in adults with narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2). Alixorexton is the company’s novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development for the treatment of NT1, NT2 and idiopathic hypersomnia (IH).